Discoverability of Rare Melanoma Clinical Trials Supplemental Table 1

Published: 17 December 2025| Version 1 | DOI: 10.17632/f6rws6yc9t.1
Contributors:
Jack Kollings,
,
,

Description

This dataset contains the trial-level coding used in “Incomplete subtype labeling on ClinicalTrials.gov limits discoverability of acral and mucosal melanoma trials: a cross-sectional analysis.” Records were retrieved from ClinicalTrials.gov using “melanoma” AND (“acral” OR “mucosal” OR “mucosa”) with interventional studies first posted ≥2015 and then deduplicated by NCT ID. The primary sheet (“Supplemental Table 1”) includes one row per included therapeutic trial and structured fields extracted from ClinicalTrials.gov (e.g., title, first-posted date, sponsor/funder type, phase, masking, arms, region) plus binary indicators showing whether subtype terms appear in specific registry fields (Title, Condition(s), Brief Summary, Detailed Description, Eligibility/Inclusion/Exclusion, Study Arms, Outcomes, Keywords; “NA” indicates the field was absent/not applicable). An “Excluded” sheet lists excluded records with basic registry metadata. No patient-level data are included.

Files

Institutions

  • Johns Hopkins University School of Medicine
  • Johns Hopkins University Bloomberg School of Public Health

Categories

Dermatology, Oncology, Clinical Trial, Melanoma, Referral System in Health Care System

Licence